BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7596688)

  • 41. Surfactant therapy and extracorporeal life support.
    Plötz FB
    Crit Care; 2006 Feb; 10(1):401. PubMed ID: 16420640
    [No Abstract]   [Full Text] [Related]  

  • 42. Distribution of exogenous surfactant in rabbits with severe respiratory failure: the effect of volume.
    van der Bleek J; Plötz FB; van Overbeek FM; Heikamp A; Beekhuis H; Wildevuur RH; Okken A; Bambang Oetomo S
    Pediatr Res; 1993 Aug; 34(2):154-8. PubMed ID: 8233717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.
    Hallman M; Merritt TA; Pohjavuori M; Gluck L
    Pediatr Res; 1986 Dec; 20(12):1228-35. PubMed ID: 3797115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique.
    Segerer H; van Gelder W; Angenent FW; van Woerkens LJ; Curstedt T; Obladen M; Lachmann B
    Pediatr Res; 1993 Oct; 34(4):490-4. PubMed ID: 8255683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of neonatal respiratory distress syndrome with Alveofact--results of a prospective observational study].
    Wauer RR; Schmalisch G; Rogalski M
    Klin Padiatr; 1996; 208(6):355-65. PubMed ID: 9064378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surfactant metabolism.
    Jobe AH; Ikegami M
    Clin Perinatol; 1993 Dec; 20(4):683-96. PubMed ID: 8131362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of a second dose of exogenous surfactant in rabbits with severe respiratory failure.
    Plötz FB; Stevens H; Heikamp A; Oetomo SB
    Pediatr Res; 1995 Apr; 37(4 Pt 1):476-81. PubMed ID: 7596688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
    Ho NK
    Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.